glp 1 rash from a GLP-1 explained by an allergist π, Thanks to my friend @rubin_allergy for the information in this video A Closer Look at the
Description
2. Mann JFE , et al
[DOI] [PubMed] [Google Scholar] 81.Ding WG, Gromada J (1997) Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide
This is a drug called semaglutide whose mechanism of action is through decreasing movement of food through the gut, which makes you feel full for a longer period of time
In this context, GLP-1R agonists show remarkable potential as an emerging therapeutic agent.GLP-1R agonists reduce body weight, lower blood pressure, and improve lipid levels, as well as exerting anti-inflammatory and antioxidant effects by directly acting on GLP-1R in the heart and blood vessels, thereby reducing the risk of atherosclerotic thrombotic events (Solini et al., 2023)
Key findings from the new studies: ARTIOS trial: Patients who switched to Kesimpta after experiencing relapses or MRI activity on other oral treatments showed fewer relapses, suppressed MRI activity, and over 90% achieved no evidence of disease activity (NEDA-3)
